AMGEN INC (AMGN) · Insider Trading (Form 4) SEC Filing

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-05-07 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: AMGEN INC (AMGN) CIK: 0000318154 --- Reporting Owner --- Name: Busch Matthew C. CIK: 0001987926 Role: Officer (VP, Finance & CAO) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-05-07 | Code: F (Payment of exercise/tax) Shares: -41 | Price: $331.11 Total Value: $13,575.51 Shares Owned After: 4,344 | Ownership: D (Direct) Footnotes: [F1] These shares include 39 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. --- Footnotes (Complete Index) --- F1: These shares include 39 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. --- Signature --- /s/ /s/ Matthew C. Busch (2026-05-08)